ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia

Jayesh M Bhatt, Andrew Bush, Marjo van Gerven, Andreea Nissenkorn, Michael Renke, Lian Yarlett, Malcolm Taylor, Thomy Tonia, Adilia Warris, Stefan Zielen, Shairbanu Zinna, Peter J F M Merkus

Research output: Contribution to journalArticle

23 Citations (Scopus)
3 Downloads (Pure)

Abstract

Ataxia telangiectasia (A-T) is a rare, progressive, multisystem disease that has a large number of complex and diverse manifestations which vary with age. Patients with A-T die prematurely with the leading causes of death being respiratory diseases and cancer. Respiratory manifestations include immune dysfunction leading to recurrent upper and lower respiratory infections; aspiration resulting from dysfunctional swallowing due to neurodegenerative deficits; inefficient cough; and interstitial lung disease/pulmonary fibrosis. Malnutrition is a significant comorbidity. The increased radiosensitivity and increased risk of cancer should be borne in mind when requesting radiological investigations. Aggressive proactive monitoring and treatment of these various aspects of lung disease under multidisciplinary expertise in the experience of national multidisciplinary clinics internationally forms the basis of this statement on the management of lung disease in A-T. Neurological management is outwith the scope of this document.

Original languageEnglish
Pages (from-to)565-581
Number of pages17
JournalEuropean respiratory review : an official journal of the European Respiratory Society
Volume24
Issue number138
Early online date30 Nov 2015
DOIs
Publication statusPublished - Dec 2015

Fingerprint

Ataxia Telangiectasia
Lung Diseases
Pulmonary Fibrosis
Radiation Tolerance
Interstitial Lung Diseases
Deglutition
Cough
Malnutrition
Respiratory Tract Infections
Comorbidity
Cause of Death
Neoplasms
Therapeutics

Cite this

ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia. / Bhatt, Jayesh M; Bush, Andrew; van Gerven, Marjo; Nissenkorn, Andreea; Renke, Michael; Yarlett, Lian; Taylor, Malcolm; Tonia, Thomy; Warris, Adilia; Zielen, Stefan; Zinna, Shairbanu; Merkus, Peter J F M.

In: European respiratory review : an official journal of the European Respiratory Society, Vol. 24, No. 138, 12.2015, p. 565-581.

Research output: Contribution to journalArticle

Bhatt, JM, Bush, A, van Gerven, M, Nissenkorn, A, Renke, M, Yarlett, L, Taylor, M, Tonia, T, Warris, A, Zielen, S, Zinna, S & Merkus, PJFM 2015, 'ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia', European respiratory review : an official journal of the European Respiratory Society, vol. 24, no. 138, pp. 565-581. https://doi.org/10.1183/16000617.0066-2015
Bhatt, Jayesh M ; Bush, Andrew ; van Gerven, Marjo ; Nissenkorn, Andreea ; Renke, Michael ; Yarlett, Lian ; Taylor, Malcolm ; Tonia, Thomy ; Warris, Adilia ; Zielen, Stefan ; Zinna, Shairbanu ; Merkus, Peter J F M. / ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia. In: European respiratory review : an official journal of the European Respiratory Society. 2015 ; Vol. 24, No. 138. pp. 565-581.
@article{c86597c62b0e4c0abca934a6cc7801ba,
title = "ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia",
abstract = "Ataxia telangiectasia (A-T) is a rare, progressive, multisystem disease that has a large number of complex and diverse manifestations which vary with age. Patients with A-T die prematurely with the leading causes of death being respiratory diseases and cancer. Respiratory manifestations include immune dysfunction leading to recurrent upper and lower respiratory infections; aspiration resulting from dysfunctional swallowing due to neurodegenerative deficits; inefficient cough; and interstitial lung disease/pulmonary fibrosis. Malnutrition is a significant comorbidity. The increased radiosensitivity and increased risk of cancer should be borne in mind when requesting radiological investigations. Aggressive proactive monitoring and treatment of these various aspects of lung disease under multidisciplinary expertise in the experience of national multidisciplinary clinics internationally forms the basis of this statement on the management of lung disease in A-T. Neurological management is outwith the scope of this document.",
author = "Bhatt, {Jayesh M} and Andrew Bush and {van Gerven}, Marjo and Andreea Nissenkorn and Michael Renke and Lian Yarlett and Malcolm Taylor and Thomy Tonia and Adilia Warris and Stefan Zielen and Shairbanu Zinna and Merkus, {Peter J F M}",
note = "ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.",
year = "2015",
month = "12",
doi = "10.1183/16000617.0066-2015",
language = "English",
volume = "24",
pages = "565--581",
journal = "European respiratory review : an official journal of the European Respiratory Society",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "138",

}

TY - JOUR

T1 - ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia

AU - Bhatt, Jayesh M

AU - Bush, Andrew

AU - van Gerven, Marjo

AU - Nissenkorn, Andreea

AU - Renke, Michael

AU - Yarlett, Lian

AU - Taylor, Malcolm

AU - Tonia, Thomy

AU - Warris, Adilia

AU - Zielen, Stefan

AU - Zinna, Shairbanu

AU - Merkus, Peter J F M

N1 - ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

PY - 2015/12

Y1 - 2015/12

N2 - Ataxia telangiectasia (A-T) is a rare, progressive, multisystem disease that has a large number of complex and diverse manifestations which vary with age. Patients with A-T die prematurely with the leading causes of death being respiratory diseases and cancer. Respiratory manifestations include immune dysfunction leading to recurrent upper and lower respiratory infections; aspiration resulting from dysfunctional swallowing due to neurodegenerative deficits; inefficient cough; and interstitial lung disease/pulmonary fibrosis. Malnutrition is a significant comorbidity. The increased radiosensitivity and increased risk of cancer should be borne in mind when requesting radiological investigations. Aggressive proactive monitoring and treatment of these various aspects of lung disease under multidisciplinary expertise in the experience of national multidisciplinary clinics internationally forms the basis of this statement on the management of lung disease in A-T. Neurological management is outwith the scope of this document.

AB - Ataxia telangiectasia (A-T) is a rare, progressive, multisystem disease that has a large number of complex and diverse manifestations which vary with age. Patients with A-T die prematurely with the leading causes of death being respiratory diseases and cancer. Respiratory manifestations include immune dysfunction leading to recurrent upper and lower respiratory infections; aspiration resulting from dysfunctional swallowing due to neurodegenerative deficits; inefficient cough; and interstitial lung disease/pulmonary fibrosis. Malnutrition is a significant comorbidity. The increased radiosensitivity and increased risk of cancer should be borne in mind when requesting radiological investigations. Aggressive proactive monitoring and treatment of these various aspects of lung disease under multidisciplinary expertise in the experience of national multidisciplinary clinics internationally forms the basis of this statement on the management of lung disease in A-T. Neurological management is outwith the scope of this document.

U2 - 10.1183/16000617.0066-2015

DO - 10.1183/16000617.0066-2015

M3 - Article

C2 - 26621971

VL - 24

SP - 565

EP - 581

JO - European respiratory review : an official journal of the European Respiratory Society

JF - European respiratory review : an official journal of the European Respiratory Society

SN - 0905-9180

IS - 138

ER -